Bernd Potthoff

- Outsourcing monitor for Preclin. and Clin.: Antibodies, Bi/Tri-specific ABs vaccines, cell based therapies. - Due diligence analysis, IND submission contribution; Subject matter expert during FDA inspection (Xolair); Briefing Book writing (Ligelizumab); Method paper writing (Kymriah); Public presentation (EBF 2018) - Bioanalytical assay development and validation for the detection of PK, PD, IG and receptor occupancy in different matrices. - SOP and Report writing, contribution to IB

- Bioanalytical assay development and validation (FACS, ELISA, ECL, AlphaLISA) for the detection of PK, PD, IG and receptor occupancy in different biological matrices. - Measurement of study samples in preclinical and clinical studies (Phase I/ II) following regulatory guidelines (EMA, FDA) and GLP/GCP. - Data collection and interpretation with WatsonLIMS. - Validation of computerized systems (FACS, EnVision). - SOP and Report writing, contribution to Investigator’s Brochures.

Head of the automated cell culture department (SelecT cell culture robot, The Automation Partnership); Assay development and high throughput screening of small molecule libraries with cell based and biochemical assays

DFG (German Research Foundation)-Scholarship holder in post graduate programme 1034 „The Impact of Inherited Polymorphismus in Oncology: From Basic Science to Clinical Application “.

Molecular biology, Microbiology, Immunology, Final degree "Ausgezeichnet" (best grade)